State laws regarding various controlled substances are sometimes puzzling, especially when it comes to cannabis.
The Wyoming Legislature recently debated whether to strengthen laws pertaining to edible or concentrated marijuana, once again failing to reach agreement on the issue. But some, particularly those suffering from chronic illness, are demanding clarity on an element of cannabis that lacks psychoactive properties — cannabidiol, most notably found in CBD oil.
Cannabidiol is one of the two main molecules in marijuana, the other being tetrahydrocannabinol, or THC, which is known to have mind-altering effects.
Recent studies suggest that CBD oil may treat epilepsy, anxiety, schizophrenia, heart disease and cancer. The molecule attaches itself to certain receptors in the body to act as a pain reliever, using methods similar to those of THC without the associated high.
Last year, a report from the World Health Organization found that no public health problems are associated with the use of CBD, suggesting it has little potential for abuse.
Wyoming is one of a number of states that have not legalized marijuana, but have laws directly related to CBD and other hemp extracts, the Wyoming Tribune Eagle reported .
During the 2015 legislative session, Wyoming’s “hemp extract bill” legalized the use of these products for registered epileptic patients. The extracts must be extremely low in THC and high in CBD — those containing less than 0.3 percent THC and more than 5 percent CBD by weight are legal with a registration card.
The law requires neurologists to provide a statement to the Wyoming Department of Health detailing how a patient would benefit from hemp extracts, after which they may qualify for registration.
Since 2015, there have been a total of 34 applications made, with 26 unique cards issued, which must be renewed annually, according to health department spokeswoman